G. S. Crowther

Evaluation of NVB302 versus vancomycin activity in an in vitro human gut model of Clostridium difficile infection

G. S. Crowther, Simon D. Baines, S. L. Todhunter et al. · Journal of Antimicrobial Chemotherapy · 2012 · 115 citations

Life Sciences, Infectious Diseases, Microbiology +14

In vitro activity of cadazolid against clinically relevant Clostridium difficile isolates and in an in vitro gut model of C. difficile infection

C. H. Chilton, G. S. Crowther, Simon D. Baines et al. · Journal of Antimicrobial Chemotherapy · 2013 · 64 citations · Full text

Life Sciences, Microbiology, Pharmacology +14

Successful treatment of simulated Clostridium difficile infection in a human gut model by fidaxomicin first line and after vancomycin or metronidazole failure

C. H. Chilton, G. S. Crowther, Jane Freeman et al. · Journal of Antimicrobial Chemotherapy · 2013 · 49 citations · Full text

Veterinary Medicine, Infectious Diseases, Pharmacology +9

Development and Validation of a Chemostat Gut Model To Study Both Planktonic and Biofilm Modes of Growth of Clostridium difficile and Human Microbiota

G. S. Crowther, C. H. Chilton, S. L. Todhunter et al. · PLoS ONE · 2014 · 47 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +17

Comparison of planktonic and biofilm-associated communities of Clostridium difficile and indigenous gut microbiota in a triple-stage chemostat gut model

G. S. Crowther, C. H. Chilton, S. L. Todhunter et al. · Journal of Antimicrobial Chemotherapy · 2014 · 46 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +17